Less than 50% of variation in HDL cholesterol between and within individuals, is explained by established predictors

被引:9
作者
Jeffs, JAR [1 ]
Godsland, IF [1 ]
Johnston, DG [1 ]
机构
[1] Univ London Imperial Coll Sci & Technol, St Marys Hosp, Fac Med, London W2 1NY, England
关键词
high density lipoprotein; triglycerides; insulin resistance; alcohol consumption; individual variation; random effects models;
D O I
10.1016/j.atherosclerosis.2005.03.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Variation in serum high density lipoprotein cholesterol (HDL-C) concentrations is believed to be largely explained by triglycerides, but this has been mainly explored in cross-sectional analyses. Eight hundred and eighty one white male participants in a health screening program attended on a total of 2158 occasions for measurements that included fasting HDL-C, low density lipoprotein cholesterol (LDL-C) and homeostasis model assessment insulin resistance (HOMA-R). Baseline, change between-visit and repeated-measures regression models were used to analyse predictors of between- and within-individual variation in HDL-C. Independent predictors of between-individual variation included serum triglycerides (20.3 or 19.6% of the variance explained, depending on the model used), body mass index (BMI: 4.7 and 4.3%), cigarette smoking (3.3 and 1.5%) and alcohol consumption (0.4 and 1.1%). Within-individual variation in HDL-C was explained by changes in serum triglycerides (4.7 and 7.5%) and BMI (5.3 and 2.9%). In multivariate models, 24.3 and 24.9% of between-individual variation in HDL-C, and 7.9 and 8.8% of within-individual variation could be explained, depending on the model used. Sixty percent of the variation in HDL-C was due to unobserved factors. The majority of variation in HDL-C remains to be explained by influences other than the conventional variables: triglyceride and LDL cholesterol concentrations, insulin resistance, smoking and alcohol. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:178 / 187
页数:10
相关论文
共 49 条
[11]  
Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477
[12]   NHLBI TWIN STUDY OF CARDIOVASCULAR-DISEASE RISK-FACTORS - METHODOLOGY AND SUMMARY OF RESULTS [J].
FEINLEIB, M ;
GARRISON, RJ ;
FABSITZ, R ;
CHRISTIAN, JC ;
HRUBEC, Z ;
BORHANI, NO ;
KANNEL, WB ;
ROSENMAN, R ;
SCHWARTZ, JT ;
WAGNER, JO .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 106 (04) :284-295
[13]   CIGARETTE-SMOKING AND HDL CHOLESTEROL - FRAMINGHAM OFFSPRING STUDY [J].
GARRISON, RJ ;
KANNEL, WB ;
FEINLEIB, M ;
CASTELLI, WP ;
MCNAMARA, PM ;
PADGETT, SJ .
ATHEROSCLEROSIS, 1978, 30 (01) :17-25
[14]  
Godsland IF, 1998, J INTERN MED, V244, P33
[15]  
GOFMAN JOHN W., 1954, PLASMA [MILAN], V2, P413
[16]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[17]   Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) [J].
Gotto, AM ;
Whitney, E ;
Stein, EA ;
Shapiro, DR ;
Clearfield, M ;
Weis, S ;
Jou, JY ;
Langendörfer, A ;
Beere, A ;
Watson, DJ ;
Downs, JR ;
de Cani, JS .
CIRCULATION, 2000, 101 (05) :477-484
[18]   High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease [J].
Gotto, AM .
AMERICAN HEART JOURNAL, 2002, 144 (06) :S33-S42
[19]   LIPOPROTEIN-CHOLESTEROL DISTRIBUTIONS IN SELECTED NORTH-AMERICAN POPULATIONS - LIPID RESEARCH CLINICS PROGRAM PREVALENCE STUDY [J].
HEISS, G ;
TAMIR, I ;
DAVIS, CE ;
TYROLER, HA ;
RIFKIND, BM ;
SCHONFELD, G ;
JACOBS, D ;
FRANTZ, ID .
CIRCULATION, 1980, 61 (02) :302-315
[20]   GENETIC AND ENVIRONMENTAL-INFLUENCES ON SERUM-LIPID LEVELS IN TWINS [J].
HELLER, DA ;
DEFAIRE, U ;
PEDERSEN, NL ;
DAHLEN, G ;
MCCLEARN, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (16) :1150-1156